Cargando…
Ontario and New Zealand Pharmaceuticals: Cost and Coverage
Ontario is a strong candidate for a comprehensive pharmacare program, given that it has a pre-existing public drug benefit program (the Ontario Drug Benefit Program [ODBP]). This paper outlines strategies from New Zealand's national pharmacare program (the Pharmaceutical Management Agency [PHAR...
Autores principales: | Kelley, Leah T., Tenbensel, Tim, Johnson, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Longwoods Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044260/ https://www.ncbi.nlm.nih.gov/pubmed/30052187 http://dx.doi.org/10.12927/hcpol.2018.25496 |
Ejemplares similares
-
Commentary: Reconsidering Pharmaceutical Research and Development Investments
por: Gagnon, Marc-André
Publicado: (2023) -
Review of Coroner Inquest Recommendations into Opioid Prescribing Practices in Ontario: Ongoing Health Policy Gaps
por: Papadomanolakis-Pakis, Nicholas, et al.
Publicado: (2019) -
The Pharmaceutical Industry and the Canadian Government: Folie à Deux
por: Lexchin, Joel
Publicado: (2017) -
A Better Prescription: Advice for a National Strategy on Pharmaceutical Policy in Canada
por: Morgan, Steven G., et al.
Publicado: (2016) -
Canada's System of Liability Coverage in the Event of Medical Harm: Is It Time for No-Fault Reform?
por: Lee, Shoo K., et al.
Publicado: (2021)